Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ASPYRE-Lung panel set up and multiple samples analyzed in US & UK test labs in as little as one day Consistent performance demonstrated across test sites and genetic variants CAMBRIDGE, United...
-
CAMBRIDGE, United Kingdom., July 28, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US headquarters in Research Triangle Park, North...
-
CAMBRIDGE, United Kingdom, July 15, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the members of its newly-formed Scientific Advisory Board (SAB) with the...
-
CAMBRIDGE, United Kingdom, April 07, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announced that it has been granted a key patent in the US protecting its...
-
CAMBRIDGE, United Kingdom, March 23, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces that the first peer review article detailing its novel...
-
Experienced US-based medical oncologist joins Biofidelity prior to launch of first diagnostic product US-trained oncologist & hematologist with over 15 years industry experience in...
-
CAMBRIDGE, United Kingdom, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr....
-
CAMBRIDGE, United Kingdom, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announced the opening of its new headquarters as it continues its significant...
-
US diagnostics executive with more than 25 years of industry commercial experienceSignificant commercial technology and diagnostic product launch expertiseTrack record of successful high-multiple...
-
Veteran Roche executive with more than 35 years of industry experiencePioneer in the early adoption of polymerase chain reaction (PCR) technologyAppointment follows completion of $12 million Series A...